Robin D. LeGallo

1.6k total citations
29 papers, 1.0k citations indexed

About

Robin D. LeGallo is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Robin D. LeGallo has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Robin D. LeGallo's work include Sarcoma Diagnosis and Treatment (8 papers), Soft tissue tumor case studies (3 papers) and Cardiac tumors and thrombi (3 papers). Robin D. LeGallo is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Soft tissue tumor case studies (3 papers) and Cardiac tumors and thrombi (3 papers). Robin D. LeGallo collaborates with scholars based in United States, Canada and Slovakia. Robin D. LeGallo's co-authors include Edward B. Stelow, Stacey E. Mills, Akeesha A. Shah, Andrew M. Bellizzi, Christopher A. French, Krishan Taneja, Jon C. Aster, Jeffery L. Kutok, Bruce M. Wenig and Charles Keller and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Chemistry.

In The Last Decade

Robin D. LeGallo

28 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin D. LeGallo United States 15 388 332 326 304 163 29 1.0k
Horia Sı̂rbu Germany 22 409 1.1× 307 0.9× 744 2.3× 357 1.2× 141 0.9× 89 1.6k
Marino E. Leon United States 22 443 1.1× 171 0.5× 284 0.9× 355 1.2× 189 1.2× 64 1.2k
Priya Kumar India 14 201 0.5× 118 0.4× 193 0.6× 204 0.7× 91 0.6× 62 781
Helen D. Brasch New Zealand 22 504 1.3× 591 1.8× 190 0.6× 389 1.3× 139 0.9× 66 1.3k
Lisa A. Cerilli United States 18 421 1.1× 183 0.6× 383 1.2× 428 1.4× 262 1.6× 37 1.2k
Abderrahim Zouhair Switzerland 18 487 1.3× 265 0.8× 389 1.2× 678 2.2× 208 1.3× 32 1.6k
Yasuyuki Kojima Japan 24 200 0.5× 435 1.3× 290 0.9× 512 1.7× 228 1.4× 91 1.5k
Gia‐Khanh Nguyen Canada 21 561 1.4× 148 0.4× 353 1.1× 332 1.1× 167 1.0× 89 1.3k
Massimo Eraldo Abate Italy 16 156 0.4× 113 0.3× 449 1.4× 145 0.5× 122 0.7× 39 780
Shintaro Iwata Japan 19 316 0.8× 203 0.6× 730 2.2× 328 1.1× 104 0.6× 104 1.2k

Countries citing papers authored by Robin D. LeGallo

Since Specialization
Citations

This map shows the geographic impact of Robin D. LeGallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin D. LeGallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin D. LeGallo more than expected).

Fields of papers citing papers by Robin D. LeGallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin D. LeGallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin D. LeGallo. The network helps show where Robin D. LeGallo may publish in the future.

Co-authorship network of co-authors of Robin D. LeGallo

This figure shows the co-authorship network connecting the top 25 collaborators of Robin D. LeGallo. A scholar is included among the top collaborators of Robin D. LeGallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin D. LeGallo. Robin D. LeGallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LeGallo, Robin D., et al.. (2020). Chromosomal microarray analysis of benign mesenchymal tumors with RB1 deletion. Human Pathology. 102. 88–93. 4 indexed citations
2.
Allison, David F., Brian D. McKenna, Stefan Bekiranov, et al.. (2019). NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer. Cell Communication and Signaling. 17(1). 24–24. 47 indexed citations
4.
Gru, Alejandro A., et al.. (2016). Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma. Annals of Diagnostic Pathology. 26. 10–15. 6 indexed citations
5.
Hu, Yinin, James R. Martindale, Robin D. LeGallo, et al.. (2015). Relationships between preclinical course grades and standardized exam performance. Advances in Health Sciences Education. 21(2). 389–399. 14 indexed citations
6.
Fox, Michael G., et al.. (2014). Epiphyseal presentation of non-Hodgkin’s lymphoma of bone in two pediatric patients—one with primary lymphoma of bone. Skeletal Radiology. 44(4). 587–595. 8 indexed citations
7.
Mills, Anne M., Marisa Meyers‐Needham, Robin D. LeGallo, et al.. (2014). From slide sets to sound bites: teaching and learning pathology in the digital age. Journal of the American Society of Cytopathology. 3(4). 183–187. 11 indexed citations
8.
Doros, Leslie, Christopher Rossi, Jiandong Yang, et al.. (2014). DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Modern Pathology. 27(9). 1267–1280. 124 indexed citations
9.
Shah, Akeesha A., Robin D. LeGallo, Annemieke van Zante, et al.. (2013). EWSR1 Genetic Rearrangements in Salivary Gland Tumors. The American Journal of Surgical Pathology. 37(4). 571–578. 88 indexed citations
10.
LeGallo, Robin D., et al.. (2012). Melanotic Xp11.2 Neoplasm of the Ovary. The American Journal of Surgical Pathology. 36(9). 1410–1414. 21 indexed citations
11.
Abraham, Jinu, Suresh I. Prajapati, Koichi Nishijo, et al.. (2011). Evasion Mechanisms to Igf1r Inhibition in Rhabdomyosarcoma. Molecular Cancer Therapeutics. 10(4). 697–707. 44 indexed citations
12.
Stelow, Edward B., Vanessa M. Shami, Christopher A. Moskaluk, et al.. (2010). Esophageal inflammatory myofibroblastic tumor sampled by EUS-FNA. Gastrointestinal Endoscopy. 72(1). 209–210. 4 indexed citations
13.
Kerr, Sarah E., Michel Kahaleh, Robin D. LeGallo, & Edward B. Stelow. (2010). Death after endoscopic retrograde cholangiopancreatography: findings at autopsy. Human Pathology. 41(8). 1138–1144. 5 indexed citations
14.
LeGallo, Robin D., et al.. (2010). Imaging characteristics of angiomatoid fibrous histiocytoma of bone. Skeletal Radiology. 40(2). 233–237. 19 indexed citations
15.
Nishijo, Koichi, Qingrong Chen, Lei Zhang, et al.. (2009). Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma. Cancer Research. 69(7). 2902–2911. 66 indexed citations
16.
Sullivan, Lisa, Kristen A. Atkins, & Robin D. LeGallo. (2009). PAX Immunoreactivity Identifies Alveolar Rhabdomyosarcoma. The American Journal of Surgical Pathology. 33(5). 775–780. 25 indexed citations
17.
Stelow, Edward B., Andrew M. Bellizzi, Krishan Taneja, et al.. (2008). NUT Rearrangement in Undifferentiated Carcinomas of the Upper Aerodigestive Tract. The American Journal of Surgical Pathology. 32(6). 828–834. 165 indexed citations
18.
Taniguchi, E, Koichi Nishijo, Amanda T. McCleish, et al.. (2008). PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma. Oncogene. 27(51). 6550–6560. 78 indexed citations
19.
Stelow, Edward B., et al.. (2008). Burkitt lymphoma. Diagnostic Cytopathology. 36(3). 172–173. 3 indexed citations
20.
LeGallo, Robin D., et al.. (2008). Diagnosis of Hydatidiform Moles Using p57 Immunohistochemistry andHER2Fluorescent In Situ Hybridization. American Journal of Clinical Pathology. 129(5). 749–755. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026